Individual low molecular weight heparins (LMWHs) exhibit distinct pharmacological and biochemical profiles because of manufacturing differences. Correlation of biological properties with particular structural motifs is a major challenge in the design of new LMWHs as well as in the development of generic versions of proprietary LMWHs. Two-dimensional nuclear magnetic resonance (NMR) spectroscopy permits identification and quantification of structural peculiarities of LMWH preparations. In this article, heteronuclear single quantum coherence spectroscopy, previously used to determine variously substituted monosaccharide components of heparan sulfate (HS) and HS-like glycosaminoglycan mimics, has been applied to the structural characterization of three commercially available LMWHs (enoxaparin, dalteparin, and tinzaparin). Relevant residues belonging to the parent heparin, as well as minor residues generated by each depolymerization procedure, have been characterized and quantified. The use of a highsensitivity NMR spectrometer (600 MHz equipped with TCI Q2 cryoprobe) allowed the accurate quantification of residues with sensitivity better than 1 to 2%.
troduced as antithrombotic agents some 20 years ago, are now replacing heparin in the treatment of most venous thromboembolic disorders. The main advantages of LMWHs over heparin are improved bioavailability and higher anti-factor (F) Xa/anti-FIIa Q3 activity ratios, with decreased hemorrhagic risk during prolonged treatments. 1 Interest in the development of generic versions of proprietary LMWHs and the recent interest in the non-anticoagulant properties of heparin and LMWHs, such as anti-inflammatory activity and inhibition of tumor cell metastasis, require a better understanding of structural requirements for these activities in both heparin and LMWHs. 2 The internal structure of LMWHs ideally should match that of the parent heparin in terms of monosaccharide composition, substitution pattern, and oligosaccharide sequence. However, the depolymerization processes involved in the manufacturing of LMWHs usually involves some structural modification. Such differences are due mostly to modifications of the monosaccharidic units at the site of cleavage and are characteristic for each depolymerization procedure. The monosaccharidic sequence of LMWHs can also be different, according to the cleavage point along the heparin polysaccharide chain. For instance, the cleavage of heparin chains at the more heavily sulfated sites, rather than undersulfated sites, 3 influences preservation and position of the specific pentasaccharide motif of the active site for antithrombin III (AT) along the oligosaccharidic chains. The high affinity binding of this pentasaccharide to AT activates this cofactor, with efficient inhibition of different proteases of the coagulation cascade, such as FXa and FIIa. The sequences containing the pentasaccharide, as well as the position in which it is located, may influence the biological properties of the LMWH chain. A tetradecasaccharide with the pentasaccharide sequence positioned at the nonreducing end was defined as optimal for bridging the AT/FII (thrombin) complex responsible for the AT-mediated inhibition of FIIa. 4 Structural modifications at the level of pentasaccharide may reduce or cancel the affinity to AT and the corresponding antiFXa (aFXa) activity. 5 Moreover, both the reducing and nonreducing extension of the pentasaccharide affects the binding properties of the oligosaccharide to AT, and consequently, its activity. 6, 7 Distinct pharmacological and biochemical profiles of LMWHs are claimed, resulting from differences in manufacture, and can be associated with structural modifications. For this reason it is increasingly important to gain a better understanding of their structureactivity relationship. 1, 8 Many efforts have been dedicated to developing analytical tools for a detailed structural characterization of preparations of LMWHs. 9 Nuclear magnetic resonance (NMR) spectroscopy has emerged as one of the most important techniques for the structural analysis of glycosaminoglycans (GAGs). Monodimensional NMR spectroscopy permits structural characterization directly on unmodified GAGs, providing information on their monosaccharide composition, sulfation pattern, positional linkages, and relative amounts of iduronic acid (I) and glucuronic acid (G) residues. 10, 11 In these applications, the area of signals in the monodimensional proton and carbon spectra, unaffected by signal overlap, are used directly for quantification. However, the structural complexity of heparin species obtained by chemical or enzymatic treatments, including LMWHs, causes strong signal overlap in the monodimensional NMR spectra, in many cases preventing their use for quantitative analyses. The possibility of extending NMR quantitative compositional analysis methods to two-dimensional (2D) 1 H-13 C correlation experiments (heteronuclear single quantum coherence [HSQC] ) was demonstrated recently. 12 The increase in resolution gained by the 2D technique allows the quantitative evaluation of signals that overlap in the corresponding monodimensional spectrum. The bidimensional method was applied Figure 1 Scheme of depolymerization used to prepare low molecular weight heparins. Major reducing and nonreducing residues obtained are shown.
STRUCTURAL DIFFERENTIATION OF LMWHs/GUERRINI ET AL
successfully to the determination of the monosaccharide composition of heparin, variously sulfated heparins, and chemically modified K5 Q4 polysaccharide derivatives.
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In this study, the approach has been extended to the most common commercially available LMWHs, focusing on quantification of the reducing and nonreducing residues generated by each depolymerization method. Two LMWHs (enoxaparin and dalteparin) obtained by chemical methods and one LMWH obtained by an enzymatic method (tinzaparin) were studied (Fig. 1) . 
STRUCTURAL FEATURES OF LMWHS
Q7 , typical of the parent heparin. Minor signals associated with undersulfated and oversulfated heparin sequences, as well as relevant signals associated with prevalent structural features of heparin, are shown in the spectra. Most of these additional signals are due to the presence of residues generated by the depolymerization process. The carbon spectra of dalteparin contains signals due to the presence of 2,5-anhydromannitol residue (AM.ol) at the reducing end (Fig. 2) . In fact, dalteparin is produced by a deamination process, in which heparin is nitrosylated at the amino group of its N-sulfoglucosamine residues. The unstable N-nitrosulfonamide residues rearrange to generate a carbocation at C2. Subsequent ring contraction and hydrolysis of the adjacent glycosidic bond generates an anhydromannose residue that is stabilized by reduction with sodium borohydride to form terminal AM.ol residues. 13 Characteristic signals corresponding to C4, C2, and C5 of AM.ol are clearly observable in the dalteparin 13 C spectrum at 87.9, 85.9, and 82.3 ppm, respectively 14 ( Fig. 2 ).
Figure 2
Q8 1 H-nuclear magnetic resonance spectra of (A) enoxaparin, (B) dalteparin, and (C) tinzaparin. Spectra were recorded at 358C on a Bruker Avance 600 spectrometer Q9 equipped with TCI Q10 5-mm cryoprobe. Water signal was presaturated during relaxation delay. Recycle delay, 10 seconds; number of scans, 164. Samples were prepared by dissolution of 12 mg of heparin in 0.6 mL of deuterium oxide. Gal, galacturonic acid; G, glucuronic acid; l.r., linkage region; A NS , 2-deoxy ) is prevalent at the reducing end. The proton spectrum of enoxaparin differs from the corresponding heparin spectrum more than that of tinzaparin (Fig. 3) . In fact, it contains signals that are not present in the tinzaparin spectrum; in particular, a small signal at 5.83 ppm corresponding to H4 of unsaturated nonsulfated uronic acid (DU) located at the nonreducing end and a signal at 3.22 ppm in the H2 region. Additional differences between enoxaparin and tinzaparin can be observed in the carbon spectra. Two additional reducing anomeric signals at 95.6 ppm, and other two signals in the C2 region of glucosamine at 55.0 and 58.6 ppm, are present in the enoxaparin spectrum. The first signal is due to the reducing N-sulfated, 6-Osulfated mannosamine (M NS ) and 2-O-sulfated iduronic acid (I 2S ) residues, the two others to the 2-sulfo-amino-1,6-anhydro-2-deoxy-b-D-glucopyranose (1,6-an.A) and 2-sulfo-amino-1,6-anhydro-2-deoxy-b-D-mannopyranose (1,6-an.M) residues; these two unique bicyclic structures present at the reducing end originating from alkaline hydrolysis of the benzoyl ester of heparin. 15, 16 These attributes of enoxaparin are peculiar to this reaction and to other side reactions that occur when fragments so generated are submitted to additional alkaline treatment.
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Signals corresponding to the linkage region (l.r.; i.e., the tetrasaccharide corresponding to the linkage of the polysaccharide chain to the peptide of the original proteoglycan 18 ) are more abundant in the tinzaparin spectrum than in either enoxaparin or dalteparin spectra, where these signals are almost absent (Fig. 2) .
Complete characterization of the structure of LMWHs is prevented by signal overlap in the monodimensional NMR spectra. In contrast, bidimensional NMR spectroscopy, particularly by using the HSQC experiment, is able to resolve and identify signals C-nuclear magnetic resonance spectra of (A) enoxaparin, (B) dalteparin, and (C) tinzaparin. Spectra were recorded at 400.13 MHz on a Bruker AMX400 spectrometer Q12 equipped with BB 10-mm probe at 408C. Spectra were recorded with proton decoupling during acquisition. Recycle delay, 2 seconds; number of scans, 16,000 with minimum overlap representing specific sulfation patterns or monosaccharidic sequences. Many signals belonging to the original heparin structure can be assigned by reference to previous NMR studies. 10, 19, 20 The HSQC spectra of the anomeric and ring regions highlight structural differences among the three LMWHs (Fig. 4) . Enoxaparin shows the most complex structure in both the anomeric and H2/C2 signals. As mentioned, two unique bicyclic structures, namely 1,6-anhydro-glucose and 1,6-anhydro-mannose are present at the reducing ends of enoxaparin chains. In fact, treatment with base also catalyzes the C2 epimerization of the hemiacetal form of reducing terminus glucosamine N,6-disulfate (A NS,6S-ared ), with partial conversion to the diastereoisomer 2-deoxy-6-O-sulfo-2-sulfamino-Dmannose (M NS,6S ). 22 Assignment of the corresponding NMR signals has been described recently in a NMR study of modified heparin disaccharides.
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A signal corresponding to 2-O-sulfated glucuronic acid residue (G 2S ), which was found in very small amounts in natural GAGs and was not detectable in spectra of non-depolymerized heparins, is clearly observable in the enoxaparin HSQC spectrum (Fig. 4A) . The HSQC-TOCSY Q20 enoxaparin spectrum (not shown) reveals the correlation between H1/C1 of G 2S and the corresponding H2/C2 (4.75/102.8 ppm and 4.17/82.4 ppm, respectively) in agreement with the characterization of heparin tetrasaccharide containing the same residue 23 ( Table 1 ). The enoxaparin HSQC spectrum also indicates the presence of epoxides generated by alkaline treatment. 24, 25 This treatment induces loss of the sulfate group at position 2 of the iduronate residue and formation of an epoxide ring between carbons 2 and 3 of this residue. In the spectrum of Fig. 4A , the two signals corresponding to the H2/C2 and H3/C3 of the epoxide group (3.74/54.2 ppm and 3.82/53.3 ppm, respectively) are highlighted. 26 The presence of epoxide in the oligosaccharidic chains may explain the formation of both L-galacturonic acid (GalA) and L-IdoA residues during the depolymerization process. 24 Conditions used during the alkaline treatment could cleave the epoxide ring, with prevalent formation a-L-ido 27 have been detected in HSQC spectra of both enoxaparin and dalteparin.
MONOSACCHARIDE COMPOSITION OF LMWHS
The analytical signals were chosen from those with minimal overlap in the HSQC spectra. Signals corresponding to monosaccharides also present in the heparin structure were chosen according to a previously published method.
12 Those that directly define specific residues typical for the LMWHs are shown in Table 2 Q25 . The prerequisite of the quantitative 2D-NMR approach is the proper selection of analytical signals from those where the effect of 1 J C-H coupling is minimal and differences in relaxation effects are sufficiently small to be neglected.
12 To verify whether the 1 J C-H set was compatible with the average value of reducing and nonreducing residues, coupled HSQC spectra were measured for enoxaparin. Results indicate that 1 J C-H of both H1/C1 and H2/C2 of reducing residues do not differ significantly from those measured for the corresponding signals associated with residues within the heparin chain (Table 3 ). In addition, the 1 J C1-H1 couplings of DU and DU 2S are close to those of the other uronic acids. However, the corresponding H4/C4 signals were chosen for the integration even if the value of 1 J C4-H4 differs from the average value of anomeric signals by $5 Hz. The overlap of the H1/C1 signal with part of the anomeric signals induces a larger error than that observed by integration of the better separated H4/C4 signals. The percentage of AM.ol residue was calculated from H2/C2 signals because its 1 J C2-H2 value is much closer to the average of the other glucosamine residues.
Given that no other signals compatible with galacturonic acid can be detected in both anomeric and H2/C2 regions of the HSQC spectrum (due to signal overlap), the H5/C5 value was used for in the calculation, even if the value of 1 J C5-H5 differed slightly (by 
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$25 Hz) from the average value of the anomeric signals of uronic acid residues. The possibility of detecting and quantifying all minor signals depends on the signal-to-noise ratio obtained in the HSQC spectrum. Application of the method to heparin/heparan sulfate preparations indicated that signals corresponding to other minor components present in amounts lower than 3 to 4%, such as those belonging to the linkage region, can be detected by HSQC spectra, but not accurately quantified. 12 In the present work, the spectra were recorded using a highfield NMR spectrometer (600 instead 500MHz) with a high-sensitivity probe (TCI cryoprobe Q31 ). This increases the sensitivity $4-fold, permitting accurate quantification of residues present in amounts below 1 to 2% (Table 4) .
The average contents of monosaccharide components of the three LMWHs are reported in Table 2 . The complexity of the enoxaparin structure compared with the other LMWHs can be appreciated immediately: eight different reducing residues are detectable in the spectra compared with the three of tinzaparin and the single reducing unit of dalteparin. In addition to the presence of different reducing residues, only small differences were observed in the monosaccharide composition.
Whereas the amount of N-sulfated glucosamine linked to glucuronic acid (A NS -G) is higher in enoxaparin, a higher A NAc content was found for tinzaparin. A slightly higher nonsulfated uronic acid content was found in enoxaparin (27%) compared with the other two LMWHs (24 to 25%). However, the total sulfation degree, calculated by adding all different sulfated monosaccharides, was almost the same (2.4/2.6) for all LMWHs, indicating that lower N-sulfation is compensated by somewhat higher O-sulfation ( Table 2 ). Given that A NS,3S is contained in the pentasaccharidic sequence of the active site of heparin for AT, its content in LMWHs should be directly associated with the aFXa activity. However, the correlation of A NS,3S with aFXa activity is not straightforward, given that signals associated with A NS,3S residues were also found in heparin fractions with no affinity for AT, indicating that this residue can also be present in different sequences that do not contribute significantly to the activity. 28 A more reliable correlation can be made between the amount of glucuronic acid linked to A NS,3S (G-A NS,3S ) and the aFXa activity, given that this disaccharide has been detected only in active sequences (Table 2 ). In fact, it has been demonstrated that heparinases I and II cleave the pentasaccharide between A NS,3S and I 2S residues, leaving the trisaccharide A NAc,6S -G-A NS,3S unit at the reducing end. Because significant aFXa activity is retained by oligosaccharides having such trisaccharide sequences at the reducing end, the G-A NS,3S disaccharide content can be considered proportional to the aFXa activities of LMWHs, as shown in Table 2 .
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As discussed, analysis of 13 C spectra indicates that all LMWHs contain a small amount of linkage region. Comparable results were obtained by HSQC (average value of the integral of the corresponding four anomeric signals) and 13 C spectra integration methods, indicating a decrease in the content of linkage region in both enoxaparin and dalteparin compared with the average value for pig mucosal heparin. 31 In contrast, the linkage region content of tinzaparin is about twice as high as that of pig mucosal heparin, clearly indicating that heparinase does not cleave the linkage region.
Another parameter that can be derived from the NMR data are the number-average mean molecular weight (Mn), which can be evaluated by integration of reducing peaks with respect to the total anomeric signals in the carbon spectrum. 32 The total amount of reducing residues, obtained by integration of the appropriate signals in HSQC spectra, can be correlated to the average length of the chains and the Mn value by estimation of the average molecular weight of the disaccharide. The calculated Mn ($3200, 4700, and 4000 d for enoxaparin, tinzaparin, and dalteparin, respectively) are substantially in agreement with those calculated by applying the HP-SEC/TDA Q35 method, 33 optimized for the analysis of LMWHs (3600, 5500, and 4600 d; manuscript in preparation).
CONCLUSION
Knowledge of the monosaccharidic composition of heparin and LMWHs is essential for deriving structureactivity relationships. The use of high-sensitivity NMR instruments permits a detailed analysis of the structural peculiarities of LMWHs, also permitting the quantification, with an acceptable error, of minor monosaccharide components. Combination of the present NMR method with disaccharide analysis performed by highperformance liquid chromatography or capillary electrophoresis, so far, is the best way to characterize heparin and heparin-like species. In addition to the structural differences typical of each manufacturing process, variation in the heparin monosaccharidic composition among the three analyzed samples was found. Such differences may also depend on structural differences among the parent heparins. Given that different pharmacokinetic profiles of LMWHs may be essentially due to their different molecular weight and polydispersity, a more exhaustive study should involve isolation of size-equivalent fractions for each LMWH.
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